المؤلفون: Kutoh, Eiji^{Aff1, Aff2, Aff3, IDs00228023035063_cor1}, Kuto, Alexandra N., Akiyama, Midori, Ozawa, Eri, Kurihara, Rumi

المصدر: European Journal of Clinical Pharmacology. :1-13

المؤلفون: Prachee Harishchandra Nirmale

المصدر: Journal of Clinical and Diagnostic Research, Vol 17, Iss 3, Pp BC16-BC20 (2023)

مصطلحات موضوعية: atherogenic lipids, chronic degenerative diseases, vitamin b12, Medicine

وصف الملف: electronic resource

Relation: https://www.jcdr.net/articles/PDF/17653/59242_CE[Ra1]_F(IS)_PF1(AG_OM)_PFA(AG_KM)_PN(KM).pdf; https://doaj.org/toc/2249-782X; https://doaj.org/toc/0973-709X

URL الوصول: https://doaj.org/article/2be963940ded42f29a5ba0e58321e97b

المؤلفون: Ziwei Ou, Zaixin Yu, Benhui Liang, Lin Zhao, Jianghua Li, Xinli Pang, Qiyun Liu, Cong Xu, Shaohong Dong, Xin Sun, Tangzhiming Li

المصدر: Frontiers in Cardiovascular Medicine, Vol 9 (2022)

مصطلحات موضوعية: evolocumab, acute coronary syndrome, atherogenic lipids, inflammatory cytokines, Chinese patients, Diseases of the circulatory (Cardiovascular) system, RC666-701

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fcvm.2022.939791/full; https://doaj.org/toc/2297-055X

URL الوصول: https://doaj.org/article/3b453401a41340059ea44b054ff1add4

المؤلفون: Natalya Semenova, Irina Madaeva, Sergey Kolesnikov, Lyubov Rychkova, Tatjana Bairova, Marina Darenskaya, Lyubov Kolesnikova

المصدر: Pathophysiology, Vol 28, Iss 1, Pp 1-9 (2020)

مصطلحات موضوعية: CLOCK 3111T/C polymorphism, atherogenic lipids, body mass index, Physiology, QP1-981

وصف الملف: electronic resource

Relation: https://www.mdpi.com/1873-149X/28/1/1; https://doaj.org/toc/1873-149X

URL الوصول: https://doaj.org/article/509571ebf4e841339a84e557c0ad3a18

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Anggoro Budi Hartopo, Irsad Andi Arso, Budi Yuli Setianto

المصدر: Acta Medica Indonesiana, Vol 48, Iss 2 (2016)

مصطلحات موضوعية: atherogenic lipids, atherogenic index of plasma, major adverse cardiovascular events, mortality, Internal medicine, RC31-1245

وصف الملف: electronic resource

Relation: http://www.actamedindones.org/index.php/ijim/article/view/147; https://doaj.org/toc/0125-9326; https://doaj.org/toc/2338-2732

URL الوصول: https://doaj.org/article/34f30c3d8be3487ea632e27754858133

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Stefano Del Prato, Maja Bujas-Bobanovic, Michael J. Louie, Alexia Letierce, Helen M. Colhoun, Desmond Thompson, Marja-Riitta Taskinen

المساهمون: Clinicum, Marja-Riitta Taskinen Research Group, Diabetes and Obesity Research Program, Research Programs Unit, University of Helsinki, HUS Internal Medicine and Rehabilitation, HUS Heart and Lung Center

المصدر: Atherosclerosis. 276

مصطلحات موضوعية: Alirocumab, Cardiovascular risk, Cholesterol-lowering drugs, Low-density lipoprotein cholesterol, Proprotein convertase subtilisin/kexin type 9, Type 2 diabetes mellitus, Male, Time Factors, MONOCLONAL-ANTIBODY, 030204 cardiovascular system & hematology, 0302 clinical medicine, ATHEROGENIC LIPIDS, Medicine, Lipoprotein cholesterol, Atherosclerotic cardiovascular disease, Anticholesteremic Agents, PCSK9 Inhibitors, Antibodies, Monoclonal, Middle Aged, 3. Good health, Pooled analysis, Treatment Outcome, Tolerability, DENSITY-LIPOPROTEIN CHOLESTEROL, Apolipoprotein B-100, lipids (amino acids, peptides, and proteins), Female, Proprotein Convertase 9, Cardiology and Cardiovascular Medicine, PCSK9 INHIBITOR EVOLOCUMAB, medicine.medical_specialty, Serine Proteinase Inhibitors, Down-Regulation, 030209 endocrinology & metabolism, AMERICAN-COLLEGE, Placebo, Antibodies, Monoclonal, Humanized, HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, POOLED ANALYSIS, 03 medical and health sciences, Double-Blind Method, Internal medicine, Humans, Aged, Dyslipidemias, business.industry, Type 2 Diabetes Mellitus, Cholesterol, LDL, Cholesterol lowering drugs, CLINICAL ENDOCRINOLOGISTS, RISK PATIENTS, Diabetes Mellitus, Type 2, 3121 General medicine, internal medicine and other clinical medicine, ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE, business, Biomarkers

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc2be6ad6155919e6415e16076369645
https://pubmed.ncbi.nlm.nih.gov/30059843